^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

mitomycin

Company:
Generic mfg.
Drug class:
DNA synthesis inhibitor
Related drugs:
3d
New P1 trial
|
mitomycin • Tomudex (raltitrexed)
7d
TAPI-1 Combined With Silicone Stents Alleviated Severe Traumatic Tracheal Stenosis via the ADAM17/TGF-β1 Pathway. (PubMed, Can Respir J)
Tracheal epithelial cells were stimulated with GM-CSF and then treated after 24 h by lentivirus-mediated ADAM17 RNAi and mitomycin C. A model of severe traumatic tracheal stenosis was established in Beagle dogs...In conclusion, it was showed that TAPI-1 combined with silicone stents can significantly alleviate severe traumatic tracheal stenosis in Beagle dogs by inhibiting the ADAM17/TGF-β1 signaling pathway and expanding the narrowed trachea. TAPI-1 combined with silicone stents can be considered as a novel therapeutic approach for treating severe tracheal stenosis after trauma.
Journal
|
EGFR (Epidermal growth factor receptor) • TNFA (Tumor Necrosis Factor-Alpha) • CSF2 (Colony stimulating factor 2) • TGFB1 (Transforming Growth Factor Beta 1) • ADAM17 (ADAM Metallopeptidase Domain 17) • NECTIN1 (Nectin Cell Adhesion Molecule 1)
|
mitomycin
14d
Targeting the DNA damage response prevents regrowth of colorectal peritoneal metastasis-derived organoids following treatment with mitomycin C. (PubMed, Br J Cancer)
PMDOs can be completely eradicated if MMC treatment is followed by inhibition of ATR or other DDR kinases. DDR inhibitors may therefore have value in the adjuvant treatment of peritoneal metastases following CRS-HIPEC.
Journal
|
CHEK1 (Checkpoint kinase 1)
|
oxaliplatin • adavosertib (AZD1775) • irinotecan • berzosertib (M6620) • ceralasertib (AZD6738) • elimusertib (BAY 1895344) • mitomycin • rabusertib (LY 2603618)
29d
Stem Cell-Related Gene CALR as a Novel Prognostic Factor for Bladder Cancer: Implications for Immunotherapy. (PubMed, Hum Mutat)
Additionally, the study explored the correlation between CALR and immune cell infiltration, as well as its interaction with mitomycin using molecular docking methods...Laboratory investigations have demonstrated that reducing CALR expression can lessen the stemness features of BLCA. Our results highlight the critical role of genes related to stem cells in BLCA and identify CALR as a promising target associated with stem cell functionality.
Journal • IO biomarker • CALR
|
CALR (Calreticulin)
|
mitomycin
1m
REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation (clinicaltrials.gov)
P2/3, N=33, Active, not recruiting, University of Cincinnati | Recruiting --> Active, not recruiting
Enrollment closed
|
capecitabine • mitomycin
1m
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis (clinicaltrials.gov)
P2, N=40, Recruiting, Mayo Clinic | Trial completion date: May 2027 --> Jul 2029 | Trial primary completion date: May 2026 --> Jul 2029
Trial completion date • Trial primary completion date
|
KRAS (KRAS proto-oncogene GTPase)
|
cisplatin • albumin-bound paclitaxel • mitomycin
1m
Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in 92 Patients with Peritoneal Metastases from Appendiceal Goblet Cell Adenocarcinoma. (PubMed, Ann Surg Oncol)
CRS and HIPEC provide 14% 5-year survival for GCA with peritoneal metastases. Complete cytoreduction, especially with PCI < 20, improves outcomes.
Journal
|
MUC16 (Mucin 16, Cell Surface Associated)
|
mitomycin
1m
Squamous cell carcinoma of unknown primary in the pelvis after complete remission following chemoradiotherapy: A case report. (PubMed, World J Clin Cases)
This case highlights the potential role of chemoradiotherapy in managing pelvic squamous cell CUP, achieving durable remission in selected patients.
Journal
|
KRT20 (Keratin 20)
|
5-fluorouracil • mitomycin
2ms
A novel radiosensitizer α-sulfoquinovosyl-acylpropanediol (SQAP) inhibits DNA repair pathways and sensitize cells to cancer chemotherapeutic agents. (PubMed, Sci Rep)
SQAP sensitized series of chemotherapeutic agents including doxorubicin, carboplatin, bleomycin, camptothecin, etoposide, methyl methanesulfonate, cisplatin, mitomycin C, and Taxol in canine tumor cells and V79 cells. These results suggest that broad inhibition of DNA repair may play a role in SQAP induced radiosensitization and chemosensitization.
Journal
|
RAD51D (RAD51 paralog D) • XRCC1 (X-Ray Repair Cross Complementing 1)
|
cisplatin • carboplatin • paclitaxel • doxorubicin hydrochloride • etoposide IV • mitomycin • bleomycin
2ms
Severe toxicity following genotype-guided reduced 5-FU dose in a heterozygous DPYD c.2846A>T carrier with stage III anal carcinoma: A case report. (PubMed, Cancer Chemother Pharmacol)
This case report supports the clinical utility of pre-emptive DPYD genotyping to guide initial 5-FU dosing in intermediate metabolizers, and it suggests that all patients still require close monitoring and some (particularly carriers of c.2846 A > T) may require an initial dose reduction greater than the recommended 50% to prevent severe toxicity.
Journal
|
DPYD (Dihydropyrimidine Dehydrogenase)
|
5-fluorouracil • capecitabine • mitomycin
2ms
P2 data • Journal
|
BAX (BCL2-associated X protein) • CDKN1A (Cyclin-dependent kinase inhibitor 1A)
|
TP53 mutation • TP53 wild-type
|
mitomycin
2ms
MoonRISe-3: A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer (clinicaltrials.gov)
P3, N=220, Recruiting, Janssen Research & Development, LLC | Trial primary completion date: Aug 2027 --> Apr 2028
Trial primary completion date
|
gemcitabine • mitomycin • erdafitinib intravesical delivery system (TAR-210)